dsg2 Antibodies

Santa Cruz Biotechnology delivers a wide array of dsg2 monoclonal antibodies for researching desmoglein 2 (dsg2) and its role in cellular adhesion. dsg2 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Desmoglein 2 is a crucial component of desmosomes, which are structures that provide strong adhesion between cells in tissues, particularly in the heart and skin. Desmoglein 2 maintains tissue integrity and participates in various cellular processes, including signaling pathways that regulate cell proliferation and differentiation. Research has shown that dsg2 alterations are linked to several diseases, including autoimmune disorders and certain types of cancer. Understanding dsg2 function and regulation continues to be an active area of investigation in cell biology and disease research. Exploring dsg2's role in tissue development and homeostasis remains crucial for advancing our knowledge of cellular adhesion mechanisms. Current research focuses on understanding how dsg2 modifications influence disease progression and potential therapeutic interventions. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of desmoglein 2's role in health and disease.